Publications

December 11, 2021

ASH Annual Meeting 2021 – Poster Presentation 2939

CD33-CLL1 Treatment System, Platform

Multiplex Engineering of Human CD34+ HSPCs Enables Dual Gene Knockout While Maintaining High Engraftment Potential and Safety